Jazz Pharmaceuticals plc
US ˙ NasdaqGS ˙ IE00B4Q5ZN47

SecurityJAZZ / Jazz Pharmaceuticals plc
InstitutionUbs Ag
Latest Disclosed Ownership145,410 shares
Latest Disclosed Value $ 23,347,000
Ubs Ag ownership in JAZZ / Jazz Pharmaceuticals plc

On November 12, 2014 - Ubs Ag filed a 13F-HR form disclosing ownership of 145,410 shares of Jazz Pharmaceuticals plc (US:JAZZ) valued at $23,347,030 USD as of September 30, 2014. The entity filed a previous 13F-HR on August 14, 2014 disclosing 332,376 shares of Jazz Pharmaceuticals plc. This represents a change in shares of -56.25% during the quarter. The current value of the position is $33,579,531 USD.

Ubs Ag has a history of taking positions in derivatives of the underlying security (JAZZ) in the form of stock options. The firm currently holds call options representing 8,800 of underlying shares valued at $1,413,000 USD and put options representing 6,600 of underlying shares valued at $1,060,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

JAZZ / Jazz Pharmaceuticals plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2014-11-12 2014-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 145,410 -186,966 -56.25 23,347 -52.22 0.0172
2014-08-14 2014-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 332,376 159,018 91.73 48,862 103.24 0.0382
2014-05-16 2014-03-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 173,358 -26,074 -13.07 24,041 -4.75 0.0214
2014-05-15 2014-03-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 173,358 24,041
2014-05-21 2013-12-31 13F/A-1 JAZZ PHARMACEUTICALS SHS USD G50871105 199,432 -674 -0.34 25,240 37.14 0.0236
2014-02-14 2013-12-31 13F JAZZ PHARMACEUTICALS SHS USD G50871105 199,432 25,240
2013-11-13 2013-09-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 200,106 94,342 89.20 18,404 153.18 0.0188
2013-08-14 2013-06-30 13F JAZZ PHARMACEUTICALS SHS USD G50871105 105,764 105,764 7,269 0.0086
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F JAZZ PHARMACEUTICALS SHS USD Call 8,800 -17.76 1,413 -10.17 n/a n/a n/a
2014-08-14 2014-06-30 13F JAZZ PHARMACEUTICALS SHS USD Call 10,700 20.22 1,573 27.47 n/a n/a n/a
2014-05-16 2014-03-31 13F/A JAZZ PHARMACEUTICALS SHS USD Call 8,900 -65.10 1,234 -61.76 n/a n/a n/a
2014-05-15 2014-03-31 13F JAZZ PHARMACEUTICALS SHS USD Call 8,900 1,234 n/a n/a n/a
2014-05-21 2013-12-31 13F/A JAZZ PHARMACEUTICALS SHS USD Call 25,500 45.71 3,227 100.56 n/a n/a n/a
2014-02-14 2013-12-31 13F JAZZ PHARMACEUTICALS SHS USD Call 25,500 3,227 n/a n/a n/a
2013-11-13 2013-09-30 13F JAZZ PHARMACEUTICALS SHS USD Call 17,500 503.45 1,609 708.54 n/a n/a n/a
2013-08-14 2013-06-30 13F JAZZ PHARMACEUTICALS SHS USD Call 2,900 199 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F JAZZ PHARMACEUTICALS SHS USD Put 6,600 -96.04 1,060 -95.68 n/a n/a n/a
2014-08-14 2014-06-30 13F JAZZ PHARMACEUTICALS SHS USD Put 166,800 7,152.17 24,521 7,586.83 n/a n/a n/a
2014-05-16 2014-03-31 13F/A JAZZ PHARMACEUTICALS SHS USD Put 2,300 -77.88 319 -75.76 n/a n/a n/a
2014-05-15 2014-03-31 13F JAZZ PHARMACEUTICALS SHS USD Put 2,300 319 n/a n/a n/a
2014-05-21 2013-12-31 13F/A JAZZ PHARMACEUTICALS SHS USD Put 10,400 -52.73 1,316 -34.98 n/a n/a n/a
2014-02-14 2013-12-31 13F JAZZ PHARMACEUTICALS SHS USD Put 10,400 1,316 n/a n/a n/a
2013-11-13 2013-09-30 13F JAZZ PHARMACEUTICALS SHS USD Put 22,000 378.26 2,024 540.51 n/a n/a n/a
2013-08-14 2013-06-30 13F JAZZ PHARMACEUTICALS SHS USD Put 4,600 316 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.